Transcript View presentation

Funding for Innovation
Sue Dunkerton, HealthTech and Medicines KTN
11 December 2012
Building a Healthy Nation through
Business Innovation
The HealthTech and Medicines KTN (Health KTN) supports business
innovations through partnerships, access to funding and knowledge
transfer
Connecting Partners
• Bringing together & facilitating collaborations with a common goal
Access to Funding
• Identify and influence new and existing sources of funding
Knowledge Transfer
• Opening doors to wider networks of people/organisations
Health KTN Priority Areas
Emerging
Medical
Technologies
Novel
High Value
Manufacturing
Regenerative
Medicine
Synthetic
Biology
Detection and
Identification of
Infectious Agents
Assisted Living
Clinical Needs
Therapies
Stratified Medicine
Finance For Innovation
8
7-9
Commercialisation
9
7-9
Commercialisation
Technology Readiness Level for Finance for
Innovation in the UK and Europe.
Businesses
Business Angels
Venture Capitalists
Private Investors
Research Councils- Responsive Mode Research,
KTA
4
2
1
TSB National- Grant for R&D, Biomedical Catalyst ,
SMART, Innovation Vouchers
Europe-PPP’s, Research for SMEs, Eureka/Eurostars
4-6 Applied Research
5
Devolved Administration/Regional Funding- R&D
Grant Scotland, Welsh Government
TSB National-Innovation Platforms, Collaborative R&D,
Catapults, Biomedical Catalyst
Europe- Framework 7 cooperation Health/NMP/ICT,
Research For SMEs, AAL
DoH/NIHR- Health Innovation Challenge Fund
Useful websites for more information:
3
1-3 Basic Research
TSB National & MRC- Biomedical Catalyst
Research Councils- Case Awards, Industrial
Case Awards, CDTs
Europe- Networks of Excellence
6
1-3 Basic Research
DH/NIHR- i4i
4-6 Applied Research
Research Councils- Managed programmes,
IKC’s
Devolved Administration/ Regional FundingRegional Growth Funds, Smart: Scotland
Europe- AAL
Technology Readiness Level (TRL)
TSB National- SBRI, KTP,
Biomedical Catalyst
Devolved Administration/Regional
Funding- Manufacturing Advisor
Service (MAS)
Technology Readiness Level (TRL)
7
• Technology Strategy Board (TSB) National
www.innovateuk.org
• Europe
www.fp7uk.co.uk
• Devolved Administration- www.scottish-enterprise.com,
www.bis.gov.uk/RGF , http://wales.gov.uk/funding
• DH/NIHR
www.nihr.ac.uk
• Research Councils
www.rcuk.ac.uk
Technology Strategy Board
Technology – Inspired Innovation Funding call
• The Technology Strategy Board
is to invest up to £10m in fasttrack and collaborative research
and development projects that
stimulate innovation across the
key enabling technology areas
of advanced materials,
biosciences, electronics,
sensors and photonics and
information and
communications technology
• Competition is now open and
deadline for registering express
of interest is 23rd January 2013
DH and NIHR funding
• i4i Product Development Award – 100% funding, England and Wales
only
• i4i Challenge Award – 100% funding, lead applicant must be in
England
• Health Innovation Challenge Fund – 2 themed calls a year (UK wide,
with Wellcome Trust)
• Healthcare Technology Cooperatives - Provide an excellent route into
the NHS for selected areas of unmet need 2 pilots, 6-8 launching
2013 (based in English Trust, open to national and international
businesses)
Devolved Administrations and
European Funding
• Devolved Administrations :
Welsh Assembly Government (WAG)
– £100m Welsh Life Sciences Fund
Scotland
– SMART: SCOTLAND
– Research and Development Grant
– Proof of Concept Fund
•
•
•
•
Eurostars – Supports UK SMEs
EU Framework Programme FP7 – Topics: Health, NMP, ICT, IMI (JTI)
Horizon 2020
Ambient Assisted Living
UK Government
• UKTI
– Passport to Export
– Export Marketing Research Scheme
– Overseas Market Introduction
Service
– Gateway to Global Growth
– UKTI Venture Capital Team
Fiscal Measure
• R&D tax credit for SMEs
– increased the level of superdeduction relief available to 225%
– no minimum spend requirement
• Patent Box
• £300m Enterprise Capital Funds
(ECF) programme
• UK Innovation Investment Fund
— UK Future Technologies Fund (UKFTF)•
• £50m Business Angel coinvestment Fund
– 10% rate of corporation tax on
profits from patents/IP
– applies worldwide to existing and
new IP
24% Corporate Tax Rate
KTN Support incl. Support Map
www.healthktn.org
Accessing
Networks
Accessing
Research
Capabilities
Accessing
Market
Information
Accessing
Clinical Needs
Innovation
Support Map
Accessing
Business
Support
Selling to the
NHS
Complying
with
Regulations
Accessing
Funding
http://www.healthktn.org/supportmap